Literature DB >> 19365624

The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors.

Rebecca J Tsai1, Leslie K Dennis, Charles F Lynch, Linda G Snetselaar, Gideon K D Zamba, Carol Scott-Conner.   

Abstract

BACKGROUND: As more women survive breast cancer, long-term complications that affect quality of life, such as lymphedema of the arm, gain greater importance. Numerous studies have attempted to identify treatment and prognostic factors for arm lymphedema, yet the magnitude of these associations remains inconsistent.
METHODS: A PubMed search was conducted through January 2008 to locate articles on lymphedema and treatment factors after breast cancer diagnosis. Random-effect models were used to estimate the pooled risk ratio.
RESULTS: The authors identified 98 independent studies that reported at least one risk factor of interest. The risk ratio (RR) of arm lymphedema was increased after mastectomy when compared with lumpectomy [RR = 1.42; 95% confidence interval (CI) 1.15-1.76], axillary dissection compared with no axillary dissection (RR = 3.47; 95% CI 2.34-5.15), axillary dissection compared with sentinel node biopsy (RR = 3.07; 95% CI 2.20-4.29), radiation therapy (RR = 1.92; 95% CI 1.61-2.28), and positive axillary nodes (RR = 1.54; 95% CI 1.32-1.80). These associations held when studies using self-reported lymphedema were excluded.
CONCLUSIONS: Mastectomy, extent of axillary dissection, radiation therapy, and presence of positive nodes increased risk of developing arm lymphedema after breast cancer. These factors likely reflected lymph node removal, which most surgeons consider to be the largest risk factor for lymphedema. Future studies should consider examining sentinel node biopsy versus no dissection with a long follow-up time post surgery to see if there is a benefit of decreased lymphedema compared with no dissection.

Entities:  

Mesh:

Year:  2009        PMID: 19365624     DOI: 10.1245/s10434-009-0452-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  107 in total

1.  Prospective surveillance of breast cancer-related lymphoedema in the first-year post-surgery: feasibility and comparison of screening measures.

Authors:  J M Blaney; G McCollum; J Lorimer; J Bradley; R Kennedy; J P Rankin
Journal:  Support Care Cancer       Date:  2014-11-16       Impact factor: 3.603

2.  A randomized trial of exercise on well-being and function following breast cancer surgery: the RESTORE trial.

Authors:  Roger T Anderson; Gretchen G Kimmick; Thomas P McCoy; Judith Hopkins; Edward Levine; Gary Miller; Paul Ribisl; Shannon L Mihalko
Journal:  J Cancer Surviv       Date:  2011-12-10       Impact factor: 4.442

3.  Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.

Authors:  Takamaru Ashikaga; David N Krag; Stephanie R Land; Thomas B Julian; Stewart J Anderson; Ann M Brown; Joan M Skelly; Seth P Harlow; Donald L Weaver; Eleftherios P Mamounas; Joseph P Costantino; Norman Wolmark
Journal:  J Surg Oncol       Date:  2010-08-01       Impact factor: 3.454

4.  Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema.

Authors:  Justin C Brown; Andrea L Cheville; Julia C Tchou; Susan R Harris; Kathryn H Schmitz
Journal:  Support Care Cancer       Date:  2013-09-07       Impact factor: 3.603

5.  Quantitative and morphologic change associated with breast cancer-related lymphedema. Comparison of 3.0T MRI to external measures.

Authors:  Gregory C Gardner; Joshua P Nickerson; Richard Watts; Lee Nelson; Kim L Dittus; Patricia J O'Brien
Journal:  Lymphat Res Biol       Date:  2014-03-21       Impact factor: 2.589

6.  Risk Factors for Arm Lymphedema in a Cohort of Breast Cancer Patients Followed up for 10 Years.

Authors:  René Aloisio da Costa Vieira; Allini Mafra da Costa; Josue Lopes de Souza; Rafael Richieri Coelho; Cleyton Zanardo de Oliveira; Almir José Sarri; Renato José Affonso Junior; Gustavo Zucca-Matthes
Journal:  Breast Care (Basel)       Date:  2015-12-14       Impact factor: 2.860

7.  Small Numbers of CD4+ T Cells Can Induce Development of Lymphedema.

Authors:  Catherine L Ly; Daniel A Cuzzone; Raghu P Kataru; Babak J Mehrara
Journal:  Plast Reconstr Surg       Date:  2019-03       Impact factor: 4.730

8.  Patient compliance with a health care provider referral for an occupational therapy lymphedema consult.

Authors:  Sally A Dominick; Loki Natarajan; John P Pierce; Hala Madanat; Lisa Madlensky
Journal:  Support Care Cancer       Date:  2014-02-14       Impact factor: 3.603

9.  Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors.

Authors:  Nandita Das; Richard N Baumgartner; Elizabeth C Riley; Christina M Pinkston; Dongyan Yang; Kathy B Baumgartner
Journal:  J Cancer Surviv       Date:  2015-04-26       Impact factor: 4.442

10.  Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) for Prevention of Breast Cancer-Related Lymphedema-a Preliminary Report.

Authors:  Juhi Agrawal; Sandeep Mehta; Ashish Goel; Pankaj Kumar Pande; Kapil Kumar
Journal:  Indian J Surg Oncol       Date:  2018-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.